Skip to main content
Home

Main navigation

  • Our Company
    • Who we are
    • Executive Committee
    • Board of Directors
    • Scientific Advisory Committee
  • Our Solutions
    • AGROBODY Foundry™
    • Product pipeline
    • Evoca™
  • Investors
    • Press releases
    • Financial information
    • Stock Information
    • Shareholder information
    • Corporate governance
    • Events
    • Presentations
    • Fact sheets
    • IPO
  • Partnering
  • News & Events
    • Press releases
    • Events
    • Stay in touch
    • Interview with our CEO
  • Careers
    • Open Postitions
    • Vision & Values
    • What our employees say
    • Benefits and wellbeing
  • Contact

User account menu

  • Log in
Go back

Biotalys announces Intention to Launch an Initial Public Offering on Euronext Brussels

Press Release

Social Menu

  • Twitter
  • LinkedIn
  • Email

Press releases

Biotalys Strengthens Relationship with Investors via Private Placement of New Shares for €7 million

June 7, 2023

Biotalys Continues to Demonstrate Strength of First Biocontrol in Latest Global Field Trials

May 31, 2023

Results of the Annual and Extraordinary Shareholders’ Meeting

April 25, 2023
Discover all press releases

Footer navigation (primary)

  • Our Company
    • Who we are
    • Executive Committee
    • Board of Directors
    • Scientific Advisory Committee
  • Our Solutions
    • AGROBODY Foundry™
    • Product pipeline
  • Investors

Footer navigation (secondary)

  • Partnering
  • Media
    • Press releases
    • Events
    • Download section
    • Stay in touch
  • Contact

Home

Biotalys NV
Buchtenstraat 11
Ghent 9051, Belgium
Phone: +32 (0)9 274 5400

Biotalys, Inc.
8480 Honeycutt Road, Suite 215
Raleigh, NC 27615,
United States
Phone: +1 (919) 714-7437

info@biotalys.com

© Copyright 2023 Biotalys NV | Privacy Policy | General Purchasing Conditions